These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1583320)

  • 1. beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime.
    Jackson JJ; Kropp H
    J Infect Dis; 1992 Jun; 165(6):1033-41. PubMed ID: 1583320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS.
    van Langevelde P; Kwappenberg KM; Groeneveld PH; Mattie H; van Dissel JT
    Antimicrob Agents Chemother; 1998 Apr; 42(4):739-43. PubMed ID: 9559775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent activity of meropenem against Escherichia coli arising from its simultaneous binding to penicillin-binding proteins 2 and 3.
    Sumita Y; Fukasawa M
    J Antimicrob Chemother; 1995 Jul; 36(1):53-64. PubMed ID: 8537284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus.
    Hayes MV; Orr DC
    J Antimicrob Chemother; 1983 Aug; 12(2):119-26. PubMed ID: 6413485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two carbapenems, SM-7338 and imipenem: affinities for penicillin-binding proteins and morphological changes.
    Sumita Y; Fukasawa M; Okuda T
    J Antibiot (Tokyo); 1990 Mar; 43(3):314-20. PubMed ID: 2108953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.
    Moyá B; Beceiro A; Cabot G; Juan C; Zamorano L; Alberti S; Oliver A
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4771-8. PubMed ID: 22733064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of non-lytic beta-lactams with penicillin-binding proteins in Streptococcus pneumoniae.
    Hakenbeck R; Tornette S; Adkinson NF
    J Gen Microbiol; 1987 Mar; 133(3):755-60. PubMed ID: 3309169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of PBP 3 entails resistance to imipenem in Listeria monocytogenes.
    Pierre J; Boisivon A; Gutmann L
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1695-8. PubMed ID: 2126687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel resistance to imipenem associated with an altered PBP-4 in a Pseudomonas aeruginosa clinical isolate.
    Bellido F; Veuthey C; Blaser J; Bauernfeind A; Pechère JC
    J Antimicrob Chemother; 1990 Jan; 25(1):57-68. PubMed ID: 2108115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
    Chambers HF; Sachdeva M; Kennedy S
    J Infect Dis; 1990 Sep; 162(3):705-10. PubMed ID: 2387996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired imipenem uptake associated with alterations in outer membrane proteins and lipopolysaccharides in imipenem-resistant Shigella dysenteriae.
    Ghosh AS; Kar AK; Kundu M
    J Antimicrob Chemother; 1999 Feb; 43(2):195-201. PubMed ID: 11252324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
    Gunkel AG; Hechler U; Martin HH
    J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of PBP 3 in the acquisition of dicloxacillin resistance in Listeria monocytogenes.
    Gutkind GO; Ogueta SB; de Urtiaga AC; Mollerach ME; de Torres RA
    J Antimicrob Chemother; 1990 May; 25(5):751-8. PubMed ID: 2115510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of penicillin-binding protein 2 with other penicillin-binding proteins in lysis of Escherichia coli by some beta-lactam antibiotics alone and in synergistic lytic effect of amdinocillin (mecillinam).
    Gutmann L; Vincent S; Billot-Klein D; Acar JF; Mrèna E; Williamson R
    Antimicrob Agents Chemother; 1986 Dec; 30(6):906-12. PubMed ID: 3545069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of imipenem resistance acquired by three Pseudomonas aeruginosa strains during imipenem therapy.
    Vurma-Rapp U; Kayser FH; Hadorn K; Wiederkehr F
    Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):580-7. PubMed ID: 2120059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penicillin-binding protein (PBP) 2 and the post-antibiotic effect of carbapenems.
    Majcherczyk PA; Livermore DM
    J Antimicrob Chemother; 1990 Oct; 26(4):593-4. PubMed ID: 2254227
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-lactam-fosfomycin antagonism involving modification of penicillin-binding protein 3 in Pseudomonas aeruginosa.
    Reguera JA; Baquero F; Berenguer J; Martinez-Ferrer M; Martinez JL
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2093-6. PubMed ID: 2127343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial properties of SCE-2787, a new cephem antibiotic.
    Nakao M; Noji Y; Iwahi T; Yamazaki T
    J Antimicrob Chemother; 1992 May; 29(5):509-18. PubMed ID: 1624391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations affecting penicillin-binding proteins 2a, 2b and 3 in Bacillus subtilis alter cell shape and peptidoglycan metabolism.
    Shohayeb M; Chopra I
    J Gen Microbiol; 1987 Jul; 133(7):1733-42. PubMed ID: 3117967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penicillin-binding proteins of filaments of Escherichia coli induced by low concentrations of nalidixic acid, oxolinic acid, novobiocin or nitrofurantoin.
    Amaral L; Schwarz U; Lorian V
    Drugs Exp Clin Res; 1986; 12(8):653-6. PubMed ID: 3530676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.